6 news items
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
SEEL
16 May 24
MarcianoChief Communications OfficerSeelos Therapeutics, Inc
Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
SEEL
14 May 24
Anthony MarcianoChief Communications Officer
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
CAL
CALX
CMTL
19 Mar 24
Energy shares rose by 1% on Tuesday.
In trading on Tuesday, communication services shares fell by 0.2
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
CMTL
CNM
FUSN
19 Mar 24
Energy shares rose by 0.7% on Tuesday.
In trading on Tuesday, communication services shares fell by 1
Seelos Therapeutics Provides Update On Top-Line Results From Its Amyotrophic Lateral Sclerosis Study With SLS-005
SEEL
19 Mar 24
as an influential force in ALS research and in caring for the ALS community. Their unique and innovative approach continues to be a benefit
y6p38e3jhx2u3upan5 qh5nsc6
SEEL
19 Mar 24
in collaboration with The Sean M. Healey and AMG Center, which is viewed as an influential force in ALS research and in caring for the ALS community
- Prev
- 1
- Next